Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business Updates
Expects to present data at multiple scientific conferences in 20212020 year-end cash position of $412 millionFurther strengthened cash position with...
Expects to present data at multiple scientific conferences in 20212020 year-end cash position of $412 millionFurther strengthened cash position with...
NEW YORK--(BUSINESS WIRE)--Mar 24, 2021--Jefferies Financial Group Inc. (NYSE: JEF) today announced its financial results for the three months ended...
Conference Call on Thursday, March 25, 2021 at 4pm ETRESTON, Va., March 24, 2021 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:...
Positive End-of-Phase 2 meeting with the FDA for entospletinib in newly diagnosed NPM1-mutated acute myeloid leukemiaFirst patient dosed in Phase...
Entered into Exclusive License Agreement, with $7.5 Million Upfront License Fee and Potential to Receive up to an Additional $194.5...
- Initiated Phase 1 clinical trial for IDE397, a potential best-in-class MAT2A inhibitor for patients having tumors with MTAP-deletion- Planning...
BOCA RATON, Fla., March 22, 2021 (GLOBE NEWSWIRE) -- Newtek Business Services Corp. (“Newtek” or the “Company”) (Nasdaq: NEWT), an...
FDA Type C meeting communications support plans to initiate Phase 2 in Q2 with NM-002 for short bowel syndrome (SBS)...
Conference call to discuss financial and operational results scheduled for Tuesday, March 23 at 8:00 a.m. U.S. Eastern TimeLaunched first...
Enterprise to host convention simply call and webcast at 8:30 a.m. EDTCARMIEL, Israel, March 22, 2021 /PRNewswire/ -- Protalix BioTherapeutics,...
TipRanks3 Monster Progress Shares With Probable for Further GainsAt the close of the day, investors want to see returns. To...
Entered 2021 with a Focus on Cancer Immunotherapy and Next-Generation Infectious Vaccines and a Strong Balance Sheet Conference Call Begins...
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional...
Luminar Systems, Inc. (NASDAQ: LAZR), the international chief in automotive lidar hardware and software package engineering, is saying now business...
TipRanks3 Huge Dividend Shares Yielding at Minimum 8% Analysts Say ‘Buy’Do you like roller coasters? In accordance to Deutsche Lender,...
Conference Call and Webcast Today at 8:30 a.m. ETCOVID-19 vaccine candidate, COVAXIN™, demonstrates efficacy of 81% in Phase 3 interim...
TipRanks3 Big Dividend Shares Yielding at Minimum 8% Analysts Say ‘Buy’Do you like roller coasters? In accordance to Deutsche Bank,...
WATERTOWN, Mass.--(BUSINESS WIRE)--Mar 18, 2021--SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today...